4/2
08:24 am
krbp
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial [Yahoo! Finance]
Medium
Report
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial [Yahoo! Finance]
4/2
08:18 am
krbp
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
Medium
Report
Kiromic BioPharma Reports Favorable Safety, Tolerability, and Early Efficacy from Third Patient in Deltacel-01 Clinical Trial
3/19
08:15 am
krbp
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial [Yahoo! Finance]
High
Report
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial [Yahoo! Finance]
3/19
08:08 am
krbp
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
High
Report
Early Efficacy Results Show Primary Lung Tumor Stabilization and Complete Disappearance of Brain Metastases in Second Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial
3/1
08:08 am
krbp
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
Medium
Report
Kiromic BioPharma Adds Virginia Oncology Associates, PC as the Second Clinical Trial Site in the Ongoing Phase 1 Deltacel-01 Trial
2/28
06:30 pm
krbp
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
Medium
Report
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
2/28
04:20 pm
krbp
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th [Yahoo! Finance]
Medium
Report
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th [Yahoo! Finance]
2/28
04:12 pm
krbp
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th [Financial Post (Toronto, Ontario, Canada)]
Medium
Report
Kiromic BioPharma to Present at the OTC Markets' Virtual Life Science Investor Forum on March 7th [Financial Post (Toronto, Ontario, Canada)]
2/28
04:09 pm
krbp
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
Medium
Report
Kiromic BioPharma to Present at the OTC Markets’ Virtual Life Science Investor Forum on March 7th
2/14
08:23 am
krbp
Results from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months [Yahoo! Finance]
High
Report
Results from First Patient in Kiromic BioPharma's Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months [Yahoo! Finance]
2/14
08:08 am
krbp
Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
High
Report
Results from First Patient in Kiromic BioPharma’s Deltacel-01 Clinical Trial Indicate Tumor Reduction at Two Months
1/29
08:02 am
krbp
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
High
Report
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer [Yahoo! Finance]
1/29
07:47 am
krbp
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer
High
Report
Kiromic BioPharma Reports Favorable Early Efficacy Results from First Patient in Deltacel-01 Phase 1 Clinical Trial in Non-Small Cell Lung Cancer